Martina Quintanar-Audelo

Title: The Innovative Contributions of Martina Quintanar-Audelo

Introduction

Martina Quintanar-Audelo is a prominent inventor based in Edinburgh, GB. She has made significant contributions to the field of biocatalysis, holding a total of 11 patents. Her work focuses on the development of engineered polypeptides that have practical applications in various industrial processes.

Latest Patents

Among her latest patents is the invention of engineered transaminase polypeptides for industrial biocatalysis. This patent provides engineered transaminase polypeptides that are useful for synthesizing chiral amine compounds under conditions relevant to industrial applications. Additionally, it includes polynucleotides encoding these engineered transaminase polypeptides, host cells capable of expressing them, and methods for using these engineered transaminases in the production of chiral amine compounds. Another notable patent is for biocatalysts and methods for the hydroxylation of chemical compounds. This invention features engineered proline hydroxylase polypeptides that facilitate the production of hydroxylated compounds, along with polynucleotides encoding these hydroxylases, host cells for expression, and methods for preparing compounds useful in the production of active pharmaceutical agents.

Career Highlights

Martina currently works at Codexis, Inc., where she continues to innovate and develop new biocatalytic processes. Her expertise in the field has positioned her as a key player in advancing biocatalysis technology.

Collaborations

Throughout her career, Martina has collaborated with notable colleagues, including Derek J Smith and Haibin Chen. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Martina Quintanar-Audelo's work exemplifies the impact of innovative thinking in the field of biocatalysis. Her patents not only showcase her expertise but also highlight the potential for engineered polypeptides in industrial applications. Her contributions continue to shape the future of biocatalytic processes.